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O1yectires. The purpose of this study was to determine whether
the Induction at electrophysiologic study of sustained monomor-
phic ventricular tachycardias with multiple QRS complex
config-
urations predicted failure of subsequent serial electrophysiologic
study guided antiarrhythmic drug testing.
Background. Ventricular tachycardias with multiple QRS com-
plex configurations are associated with failure of surgical therapy
fbr ventricular tachycardia. As such, the presence or multiple
monomorphic QRS complex ventricular tachycardias during elec-
trophysiologic testing may predict failure of subsequent medical
therapy .
Methods. Fifty-one consecutive patients with coronary artery
disease had reproducible induction of monomorphic ventricular
tachycardia during a baseline electrophysiologic study . Each
patient then underwent a mean of 1 .5 antiarrhythmic drug trials .
An antiarrhythmic drug regimen that suppressed Induction of
ventricular tachycardia was identified in 13 (26%) of the 51
patients.
Results. Patients with only one inducible monomorphic QRS
complex ventricular tachycardia at baseline study were more
Serial electrophysiologic study-guided drug testing has been
used to direct therapy in patients with ventricular tachycar-
dia. When antiarrhythmic drugs are identified that suppress
ventricular tachycardia, the outcome is favorable (1-3) . The
likelihood of identifying a successful antiarrhythmic drug
regimen that can suppress ventricular tachycardia induction
has ranged from 25% to 70% (4-9). Thus, many patients who
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likely to have an antiarrhythmic drug regimen identified that
suppressed inducible ventricular tachycardia than were patients
with multiple monomorphic QRS comp ex ventricular tachycar-
dias (12136%1 of 33 patients vs . 116%) of 18, p = 0.04) . In seven
patients with only one Induced configuration of ventricular tachy-
cardia, a second monomorphic ventricular tachycardia with a
different QRS complex configuration occurred during attempts at
pacing termination of the induced ventricular tachycardia . None
of these seven patients then had successful drug suppression of
inducible ventricular tachycardia. Thus, 12 (46%) of 26 patients
with a single monomorphic QRS complex ventricular tachycardia
observed at baseline study had successful serial drug testing
compared with 1(4%) of 25 patients with multiple QRS complex
ventricular tachycardia configurations (p = 0 .002) .
Conclusions . The induction or observation of multiple mono-
morphic QRS complex ventricular tachycardias at baseline elect
trophysiologic study predicted failure of subsequent serial electro-
physiologic study-guided antiarrhythmic drug therapy .
(J Ant Coll Cardlol 1993 ;22 :1117-22)
have unsuccessful serial electrophysiologic drug testing
must be considered for alternative therapies (10) .
Serial electrophysiologic drug testing is invasive, time-
consuming and costly . If factors that predict failure of serial
electrophysiologic drug testing were identified early, patient
care would be optimized .
Various clinical and electrophysiologic factors have been
examined to determine predictors of success or failure at
serial electrophysiologic drug testing (5-8) .
Several studies
(5,11,12) have reported that the response to intravenous
procainamide at the initial electrophysiologic study pre-
dicted the outcome of electrophysiologic antiarrhythmic
drug studies . However, other studies (13,14) have reported
otherwise .
In the surgical treattrtent of ventricular tachycardia
. the
presence of more than one monomorphic ventricular tachy-
cardia QRS complex configuration predicted failure of sur-
gical treatment of ventricular tachycardia (15-17). Morpho-
logically distinct monomorphic QRS complex ventricular
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tachycardias often originate at different left ventricular sites
(16-19). We hypothesized that the presence of more than
one QRS complex ventricular tachycardia configuration at
electrophysiologic study would also predict failure of serial
electrophysiologic study guided medical therapy .
Methods
Study patients . The study group consisted of 51 consec-
utive patients with coronary artery disease who had a
sustained monomorphic ventricular tachycardia that was
reproducibly induced at the baseline study in the absence of
antiarrhythmic drugs . These patients were selected from a
larger pool of 84 patients who had serial drug testing for
sustained monomorphic ventricular tachycardia. However,
I I patients without coronary artery disease were excluded,
and 22 patients who did not have reinduction of ventricular
tachycardia owing to hemodynamic instability during ven-
tricular lachycardia were also excluded .
There were 44 men and 7 women, with a mean age of 66
years (range 41 to 82) . All patients had coronary artery
disease, as documented by angiographic data . The mean left
ventricular ejection fraction was ;0%0 (range 9% to 60%) .
Indications for electrophysiologic study included cardiac
arrest in 5 patients, syncope in I I and documented sustained
ventricular tachycardia in 35.
Electrophyslologic study . After giving written informed
consent, all patients had a baseline electrophysiologic study
in the postabsorptive state. All antiarrhythmic drugs, ex-
cluding beta-adrenergic blocking agents and digoxin, were
discontinued for at least five half-lives before the baseline
study. Using standard techniques, multipolar electrode cath-
eters were positioned in the high right atrium, across the
tricuspid valve to record a His bundle electrogram and at the
tight ventricular apex or outflow tract, or both, for recording
and stimulation. A programmable, battery-powered stimula-
tor (Medtronic 5328) was used to deliver square:-wave stimuli
of 2,0-ms duration at twice the diastolic threshold . Surface
electrocardiographic (ECG) leads I, II, aVF, V 1 and bipolar
intracardiac electrograms were monitored and recorded on a
multichannel oscilloscope (Electronics-for-Medicine VR16
recorder), and hard copy tracings were obtained at paper
speeds of SO to 100 mmfs. All data were recorded simulta-
neously on FM magnetic tape (Honeywell model 101) .
A standard programmed ventricular stimulation protocol
was used (20). The programmed stimulation protocol in-
cluded introduction of single, double attd triple ventricular
extrastimuli after an 8-beat drive train at cycle lengths of
6+(10, 500, or 400 ms. Ventricular extrastimuli were intro-
duced to scan diastole in decrements of 10 ms until ventric-
ular tachycardia was induced or ventricular refractoriness
was achieved at two right ventricular sites. Sustained ven-
tricular tachycardia was reinduced at baseline study in the
absence of antiarrhythmic drug therapy .
Auti.rrbythwic drug rills. Serial drug testing was per-
formed, with only suppression of induction of ventricular
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Figure 1 . Electrocardiographic leads 1 . aVF and V, recorded simul-
taneously with electrograms from the high right atrium (HRA), His
bundle (HIS) and right ventricular apex (RVA) during ventricular
tachycardia and during a single pacing attempt to interrupt the
ventricular tachycardia. Note that after the introduction of the
pacing train from the right ventricular apex, a monomorphic ven-
tricular tachycardia with a different QRS complex configuration than
that of the initially induced ventricular tachycardia developed . S
stimulus artifact .
tachycardia as a positive end point . An intravenous type IA
antiarrhythmic drug was usually tested during the initial
setting after completion of the baseline study . Subsequent
electrophysiologic drug trials utilized orally administered
class IA, III, IC or III antiarrhythmic drugs. Electrophysio-
logic studies performed utilizing amiodarone were excluded
from this report .
Ventricular tachycardia QRS complex configurations. In
each patient, the 12-lead ECGs of all monomorphic ventric-
ular tachycardia QRS complex configurations were com-
pared with each other . Electrocardiographic electrodes were
placed in the standard position during the baseline study . In
defining monomorphic ventricular tachycardia QRS com-
plexes as similar, the bundle branch block pattern in lead V 1 ,
mean frontal axis to within 30° and the R wave progression
across the precordium were identical . In addition to compar-
ing the QRS configurations of all induced sustained ventric-
ular tachycardias, we also compared the QRS complex
configurations of all observed sustained monomorphic ven-
tricular tachycardias (i .e ., those that resulted from induction
at programmed stimulation or from attempted pacing termi-
nation) (Fig. 1). The data analysis was performed for
t) ventricular tachycardias that were induced by pro-
grammed stimulation, and 2) ventricular tachycardias that
were induced or resulted from attempted pacing termination .
Twenty-five patients underwent a drug trial using intra-
venous procainamide (15 mglkg body weight) after comple-
tion of the baseline study. We compared the QRS complex
configurations of all sustained ventricular tachycardias
(either induced or resulting from antitachycardia pacing)
after intravenous procainamide relative to the monomorphic
ventricular tachycardia QRS complex configurations ob-
served during the baseline study .
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Each patient's spontaneous (clinical) ventricular tachy-
cardia was not included in the analysis . At electrophysio-
logic study, polymorphic ventricular tachycardia and ven-
tricular fibrillation were excluded from analysis in this study .
Data analysis . Unpaired data were compared by the
two-tailed t test for continuous variables and by chi-square
analysis or the Fisher exact test for comparisons of propor-
tions. In addition, a stepwise multiple logistic regression
analysis was performed to determine whether any of the
following variables correlated with successful electrophysi-
ologic study guided drug therapy : age, gender, ejection
fraction, minimal number of extrastimuli required to induce
ventricular tachycardia at baseline study, induced ventricu-
lar tachycardia cycle length, number of ventricular tachycar-
dia QRS complex configurations at baseline study and clin-
ical presentation .
Definition of terms. Standard definitions were used for
sustained ventricular tachycardia . nonsustained ventricular
tachycardia, monomorphic ventricular tachycardia, multiple
monomorphic ventricular tachycardias and polymorphic
ventricular tachycardia (20) . Successful electrophysiologic
study guided therapy was defined as completion of the
ventricular stimulation protocol in the presence of antiar-
rhythmic drug therapy without inducing sustained ventricu-
lar tachycardia. Positive predictive value was defined as the
number of patients with one ventricular tachycardia QRS
complex configuration who had successful electrophysio-
logic study-guided therapy, divided by all patients with one
ventricular tachycardia QRS complex configuration . Nega-
tive predictive value was defined as the number of patients
with multiple monomorphic QRS complex ventricular tachy-
cardias who did not have successful electrophysiologic
study-guided therapy, divided by all patients with multiple
monomorphic ventricular tachycardias . Baseline study was
defined as the electrophysiologic study performed in the
absence of antiarrhythmic drugs .
Results
Electrophysiologic profile . The mean induced tachycardia
cycle length was 290 ms . The mean number of ventricular
extrastimuli required to induce ventricular tachycardia at
baseline electrophysiologic study was 2.2 t 0 .7. Patients
underwent a mean of 1 .5 antiarrhythmic drug trials .
Overall, 13 (26%) of 51 patients had successful electro-
physiologic study-guided therapy (Table I) . These 13 pa-
tients underwent a mean of 1 .4 antiarrhythmic drug trials,
whereas the 38 patients without successful electrophysio-
logic study-guided drug therapy underwent a mean of 1 .6
antiarrhythmic drug trials (p = NS) . ;4 variety of drugs or
drug combinations were used (Table 2) .
Induction of multiple monomorphic sustained ventricular
tachycardias. Eighteen (36%) of 51 patients had induction of
multiple monomorphic ventricular tachycardias at the base-
line study (Fig . 1). Only 1 (6%) of these 18 patients subse-
quently N;d successful electrophysiologic study-guided
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Table 1. Outcome of Electrophysiotogic Study in 51 Patients With
Coronary Artery Disease
VT Suppressed
	
VT Not Suppressed
(n = 13)
in = 38)
2
a
5
0
18
2
1119
Values presented are mean value ± SD or number . EPS = electrophysi-
ologic study ; VT = ventricular tachycardia,
medical therapy . However, 12 (36%) of the 33 patients with
reproducible induction of morphologically similar ventricu-
lar tachycardias at the baseline electrophysiologic study had
successful electrophysiologic study-guided medical therapy
(Fig . 2) (p = 0 .04) .
Of the 33 patients with reproducible induction of mono-
morphic ventricular tachycardia with similar QRS complex
configurations, 7 subsequently developed a monomorphic
ventricular tachycardia with a different QRS complex con-
figuration during attempted pacing termination . These seven
patients subsequently did not have successful electrophysi-
ologic study-guided medical therapy . Thus, only 1 (4%) of
25 patients with multiple ventricular tachycardia QRS com-
plex configurations observed at baseline study had success-
ful electrophysiologic drug suppression in contrast to 12
(46%) of 26 patients with only one observed ventricular
tachycardia QRS complex configuration (Fig . 3) (p = 0 .002) .
The outcome of electrophysiologic drug testing after each
of the first two drug trials is shown in Figure 4 . After baseline
study, the outcome of the first drug trial was successful in 9
of 26 patients with a single monomorphic ventricular tachy-
cardia QRS complex configuration compared with i of 25
patients with multiple monomorphic ventricular tachycardia
QRS complex configurations (p = 0 .016) . After the first drug
trial, 23 patients who had an unsuccessful first drug trial
Table 2. Drugs Used During Serial Electrophysiologic Study
Patients
(no.)
Procainamide
Intravenous
Oral
Quinidine (orall
Quinidinelmexileline (oral)
Type IC (encainide or flecainidel (oral)
Sotelol (oral)
Lidocaine linlravenousl
Encainidelmexiletine (oral)
Induced VT cycle length
296 t 16 284 ± 8
Ex(astimuli used to induce VT
at baseline EPS
(no.)
0 0
1
1
2
4
2
7
20
3 4
13
EPS drug trials
I S
I8
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2 i
P = 0.04
Number of induced VT QRS complex
configtuattons at baseline study
Figure Z, Histogram demonstrating outcome of electrophysiologic
study guided antiarrhythmic drug therapy based on the number of
ventricular tachycardia (VT) QRS complex configurations induced
at baseline study . The difference between successful therapy in the
two groups (I vs, e2) was statistically significant . Black bars -
successful therapy ; white bars
-
unsuccessful therapy . See text for
discussion .
underwent a second drug trial . Although II of these 23
patients had only one monomorphic ventricular tachycardia
QRS complex configuration at baseline, 6 of these I I pa-
tients had a second monomorphic ventricular tachycardia
QRS complex configuration induced during the first drug
trial . Thus, after the second drug trial, 5 of the 23 patients
still had only one monomorphic ventricular tachycardia QRS
complex configuration. None of 18 patients who had two
monomorphic ventricular tachycardia QRS complex config-
urations after one drug trial subsequently had a successful
second drug trial. However, three of the five patients with a
single ventricular tachycardia QRS complex configuration
after the first unsuccessful drug trial subsequently had a
successful electrophysiotogic study-guided drug trial .
Three or more monomorphic ventricular tachycardla QRS
complex con6gurathtns. No patients with three or more
monomorphic ventricular tachycardia QRS complex config-
urations had successful electrophysiologic study-guided
therapy. After the baseline study and serial -studies, 16% and
Figure 3 . Histogram demonstrating outcome of electrophysiologic
study-guided antiarrhythmic drug therapy based on the number of
ventricular tachycardia (VT) QRS complex configurations observed
at baseline study (including ventricular tachycardias resulting from
attempted pacing termination). The difference between successful
therapy in the two groups (I vs. a2) was statistically significant .
Symbols as in Figure 2. See text for discussion .
P a 0
.002
24
1
e2
Number of observed VT QRS complex
configurations at baseline study
• number of VT
coatiguraticns after
baseline study
• drug trial 1 :
success?
• number of patients
Undergoing a
s cam drug trial
• number of VT
conflcJrations after
1 drug study
• drug trial 2:
success? n
26
51 patients
25
>1
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Figure 4. Flowchart of outcome of serial electrophysiologic testing .
After the first antiarrhythmic drug trial, those patients with one
ventricular tachycardia (VT) QRS complex configuration were more
likely to have successful cleclrophysiologic study-guided therapy
than were patients with multiple monomorphic QRS complex con-
figurations (p ~ 0.016) . Of those patients who had an unsuccessful
first antiarrhythmic drug trial and had a second electrophysiologic
study-guided antiarrhythmic drug trial, 3 of 5 patients with one
ventricular tachycardia QRS complex configuration had successful
guided therapy compared with none of 18 patients with multiple
ventricular tachycardia QRS complex configurations . It = no (not
successful) ; y = yes (successful) . See text for discussion .
41% of patients had three or more ventricular tachycardia
configurations, respectively .
Predictive value. The negative predictive value was con-
sistently high, ranging from 94% to 97% . The positive
predictive value ranged from 3611/6 to 60%0 (Table 3) . The
consistently high negative predictive value indicated that the
observation of two or more ventricular tachycardia QRS
complex configurations predicted failure of serial electro-
physiologic study-guided drug testing. Therefore, a second
monomorphic QRS complex ventricular tachycardia,
whether observed at baseline study during reinduction, at
baseline study during attempted pacing termination or at
drug trial testing, predicted failure of electrophysiologic
study-guided drug therapy .
Stepwise multiple logistic regression analysis . We exam-
ined several other clinical and electrophysiologic variables
Table 3. Positive (+) and Negative I-I Predictive Values of the
Number of Monomorphic Ventricular Tachycardia Configurations
Induced configurations = monomorphic QRS complex ventricular tachy-
cardia configurations that resulted from programmed
stimulation induction:
observed configurations = monomorphic QRS complex ventricular lachycar-
dia configurations that resulted from programmed stimulation induction or
attempted pace termination .
Baseline study
Induced configurations
36% 94%
Observed configurations 46% 96%
Initial study (baseline study and intravenous
60% 97%
procainamide trial)
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Table 4. Multivariate Stepwise Logistic Regression Analysis
p Value
Age
Gender
Left ventricular election fraction
N .. . of extrastimuli to induce VT
Induced VT cycle length
1 versus y2 VT QRS complex configurations
Mode of clinical presentation
VT = ventricular tachycardia.
to determine whether they predicted outcome . The number
of monomorphic ventricular tachycardia QRS complex con-
figurations (p = 0.01) and left ventricular ejection fraction
(p = 0.03) demonstrated significance on multivariate logistic
stepwise regression analysis ('table 4) .
Discussion
Prognostic significance of multiple mmtanorphic ventricu-
lar tachycardia configurations during serial electrophysiologic
testing. Previous studies have shown that patients with
recurrent ventricular tachycardia often exhibit multiple QRS
complex configurations (1,18,19,21-23) . Wilber et al . (21)
reported that 61% of patients had induced ventricular tachy-
cardias with different QRS complex configurations at elec-
trophysiologic study. Furthermore, Cooper et al . (22)
showed that ventricular tachycardias with different QRS
complex configurations were reinduced in 36% of patients
during one baseline study and in 74% of patients during
baseline studies repeated on different days . Our study again
demonstrated that monomorphic ventricular tachycardias
with multiple QRS complex configurations are commonly
induced during electrophysiologic study,
More important, this study demonstrated that initiation of
monomorphic ventricular tachycardias with multiple QRS
complex configurations at baseline study predicted subse-
quent failure of electrophysiologic study-guided testing . In
our study, multiple ntonomtirphic QRS complex ventricular
tachycardias were initiated either by inducing morphologi-
cally different tachycardias wi .h programmed ventricular
stimulation or by attempted racing termination of ventricu-
lar tachycardia. Furthermore, our results showed that the
occurrence of multiple monomorphic QRS complex ventric-
ular tachycardias had a high negative predictive value
whether they were observed during induction or attempted
pacing termination at the baseline state or during drug
testing . Therefore, by counting all observed sustained ven-
tricular tachycardias rather than only all induced ventricular
tachycardias at baseline, study, more patients were found to
have multiple QRS complex ventricular tachycardia config-
urations (49% vs. 36%). Regardless of how and when multi-
ple monomorphic ventricular tachycardia QRS complex
configurations were present during the course of serial
electrophysiologic studies, our data indicate that their pres-
NS
NS
0.03
NS
NS
0.0I
NS
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ence indicated a very low likelihood of finding a successful
electrophysiologic study-guided drug .
Predictors cf success or failure of serial electrophysiologic
studieF . In our study, multiple monomorphic QRS complex
ventricular tachycardias and a low left ventricular ejection
fraction were independent predictors of failure of serial
electrophysiologic drug studies. Past studies have shown
low left ventricular ejection fraction to be a useful predictor
of this outcome (5,7) . The absence of coronary artery
disease has been observed to be a predictor of success of
serial drug studies (8). Other useful predictors previously
cited include the nature of the present , ;,g arrhythmia . induc-
tion of ventricular tachycardia with one ventricular extra-
stimulus and response to intravenous procainamide (5-7) .
Although a positive response to intravenous procaina-
mide has been cited as a useful predictor, a negative re-
sponse to intravenous procainamide has been reported to
have limited utility (5) . In our study, after one unsuccessful
drug trial (oral or intravenous), 3 (60%) of 5 patients who still
had only one observed ventricular tachycardia QRS complex
configuration subsequently had suppression of ventricular
tachycardia induction at the second trial compared with
none of 18 patients who had multiple monomorphic ventric-
ular tachycardia configurations observed . Therefore, in our
study, a negative response to a first drug trial did not
necessarily predict subsequent failure. Rather, it depended
on the number (one or two or more) of monomorphic
ventricular tachycardia QRS complex configurations ob-
served .
Limitations of the study . Because this was a retrospective
review, the same rigid electrophysiologic study protocol was
not followed in all patients . Only patients who had repro-
ducible induction of sustained monomorphic ventricular
tachycardia were included in this study . Therefore, we
cannot comment on those patients who did not have rein-
duction of ventricular tachycardia performed, which gener-
ally included patients with inducible, rapid ventricular tachy-
cardia that was either hemodynamically unstable or
degenerated to ventricular fibrillation .
Additionally, only 49% of patients received an intrave-
nous trial of procainamide . Had more patients und : rgone an
intravenous antiarrhythmic drug trial, more patients might
have demonstrated multiple monomorphic QRS complex
ventricular tachycardias . However, lack of consistency of
intravenous procainamide testing does not limit the results
or conclusions with regard to multiple monomorphic ventric-
ular tachycardia configurations observed at baseline study .
Patients in our study had a mean of 1 .5 drug trials
.
Successful suppression of ventricular tachycardia induction
is often achieved in the first one to two drug trials (9) . Given
that the number of drug trials in our study was relatively
small, a bias may have been introduced . The probability of
inducing multiple monomorphic QRS
complex tachycardias
might have increased had more drug trials been performed .
However, this bias may be difficult to sort out because
1122
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patients and physicians are increasingly unwilling to undergo
numerous electrophysiologic trials to assess drug efficacy .
We included in our analysis monomorphic ventricular
tachycardia that resulted from attempted pacing termination
of an initially induced ventricular tachycardia . Because
these ventricular tachycardias may be considered "nonclin-
ical. " it remains controversial
whether they indeed identify
patients with multiple monomorphic ventricular tachycar-
dias. In our series, in all patients with a morphologically
distinct monomorphic ventricular tachycardia resulting from
antitachycardia pacing, serial drug testing failed . Thus, we
believe that the presence of multiple monomorphic ventric-
ular taehycardias, regardless of how the tachycardia was
induced, identifies patients with a very low probability of
having successful antlarrhythmic drug therapy selected by
serial electrophysiologic study-guided drug testing.
Clinical implications . Because of the increasing economic
pressure on physicians to limit diagnostic tests and hospital
days, we suggest that the following strategy may streamline
serial electrophysiologic drug testing . At each step during
serial electrophysiologic studies, patients can be stratified by
the number of monomorphic ventricular tachycardia QRS
complex configurations observed . Whenever two or more
configurations are observed, the patient should be consid-
ered for alternative modes of treatment. However, for those
patients who have only one demonstrated ventricular tachy-
cardia QRS complex configuration, serial electrophysiologic
study-guided drug testing should be pursued .
Conclusions. In patients with coronary artery disease,
multiple monomorphic ventricular tachycardia QRS com-
plex configurations during baseline study predicted failure of
electrophysiologic study guided drug therapy . The observa-
tion of a second monomorphic ventricular tachycardia con-
figuration at subsequent drug trials also predicted failure of
serial electrophysiologic drug testing.
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